Alpine Associates Management Inc. Icosavax, Inc. Transaction History

Alpine Associates Management Inc.

  • $2.56 Billion
  • Q1 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$5.95 - $15.79 $8.67 Million - $23 Million
1,456,700 New
1,456,700 $23 Million

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Alpine Associates Management Inc. Portfolio

Follow Alpine Associates Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Associates Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alpine Associates Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email